Publications » Rapport Therapeutics

Nicotinic acetylcholine receptor redux: Discovery of accessories opens therapeutic vistas

Matta et al. Science (2021) 373: 6539

Read Now

Targeting receptor complexes: a new dimension in drug discovery

Rosenbaum et al. Nature Reviews Drug Discovery (2020) 19: 884

Read Now

Getting a Handle on Neuropharmacology by Targeting Receptor-Associated Proteins

Maher et al. Neuron (2017) 96: 989

Read Now

Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8

Maher et al. The Journal of Pharmacology and Experimental Therapeutics (2016) 357: 394

Read Now

RAP-219 a Novel, Potent, and Selective Negative Modulator of AMPAR/TARPγ8

Epilepsy Foundation Pipeline Conference 2024

Read Now

Novel Design of a Focal Epilepsy Proof-of-Concept Study of RAP-219, a Negative Allosteric Modulator of the γ8 Transmembrane AMPA Receptor Associated Protein (TARPγ8)

15th European Epilepsy Congress (EEC) 2024

Read Now

Early detection rate changes from a brain-responsive neurostimulation system predict efficacy of newly added antiseizure drugs

Quraishi et al, Epilepsia (2019) 61:138–148

Read Now

How do we choose the appropriate animal model for antiseizure therapy development?

Barker-Haliski et al, EXPERT OPINION ON DRUG DISCOVERY (2019) 10: 947–951

Read Now

Clinical and electrocorticographic response to antiepileptic drugs in patients treated with responsive stimulation

Skarpass, et al, Epilepsy & Behavior (2018) 83: 192–200

Read Now

RTX-1738 Exhibits Analgesic Activity Across a Broad Range of Preclinical Pain Models

International Association for the Study of Pain (IASP) 2024 World Congress on Pain

Read Now

Proteins for increased surface expression of the α6β4 nicotinic acetylcholine receptor: Nothing but good news?

Grant and Lester. The Journal of Clinical Investigation (2020) 130: 5685

Read Now

Functional α6β4 acetylcholine receptor expression enables pharmacological testing of nicotinic agonists with analgesic properties

Knowland et al. The Journal of Clinical Investigation (2020) 130:6158

Read Now

A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

Rowbotham et al. Pain (2009) 146: 245

Read Now

Hair cell α9α10 nicotinic acetylcholine receptor functional expression regulated by ligand binding and deafness gene products.

Gu et al. PNAS (2020) 117: 24534

Read Now

Enhancement of the Medial Olivocochlear System Prevents Hidden Hearing Loss

Boero et al. The Journal of Neuroscience (2018) 38: 7440

Read Now

The mammalian efferent vestibular system plays a crucial role in vestibulo-ocular reflex compensation after unilateral labyrinthectomy

Hübner et al. Journal of Neurophysiology (2017) 117: 1553

Read Now

Scientific Publications

Foundational Science

Epilepsy

Pain

Hearing/Vestibular Disorders